APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hormone Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hormone Disorder Drug Market Analysis and Forecast 2026-2032

Report ID 173999120222 December 2025193 pages

Choose your research edition.

Industry ResearchHormone Disorder Drug Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Hormone Disorder Drug Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Hormone Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hormone Disorder Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hormone Disorder Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Hormone Disorder Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hormone Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hormone Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hormone Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hormone Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Hormone Disorder Drug include Abbott, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Sanofi, Novartis AG, Merck KGaA, Lilly, Ferring B.V and PT. Daewoong Pharmaceutical Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hormone Disorder Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hormone Disorder Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Hormone Disorder Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hormone Disorder Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hormone Disorder Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hormone Disorder Drug sales, projected growth trends, production technology, application and end-user industry.

Hormone Disorder Drug Segment by Company

Abbott

Teva Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

Sanofi

Novartis AG

Merck KGaA

Lilly

Ferring B.V

PT. Daewoong Pharmaceutical Company

Mayne Pharma Group Limited

Ipsen Pharma

Genentech, Inc

F. Hoffmann-La Roche Ltd

Bausch Health Companies Inc

Amneal Pharmaceutical Inc

Hormone Disorder Drug Segment by Type

Growth Hormone Stimulator

Growth Hormone Inhibitor

Hormone Disorder Drug Segment by Application

Dwarfism

Gigantism

Other

Hormone Disorder Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hormone Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hormone Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hormone Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hormone Disorder Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hormone Disorder Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hormone Disorder Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hormone Disorder Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Growth Hormone Stimulator Major Manufacturers Table 3. Growth Hormone Inhibitor Major Manufacturers Table 4. Global Hormone Disorder Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Dwarfism Major Manufacturers Table 6. Gigantism Major Manufacturers Table 7. Other Major Manufacturers Table 8. Hormone Disorder Drug Industry Trends Table 9. Hormone Disorder Drug Industry Drivers Table 10. Hormone Disorder Drug Industry Opportunities and Challenges Table 11. Hormone Disorder Drug Industry Restraints Table 12. Global Hormone Disorder Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Hormone Disorder Drug Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Hormone Disorder Drug Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Hormone Disorder Drug Revenue Market Share by Region (2021-2026) Table 16. Global Hormone Disorder Drug Revenue Market Share by Region (2027-2032) Table 17. Global Hormone Disorder Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Hormone Disorder Drug Sales by Region (2021-2026) & (k units) Table 19. Global Hormone Disorder Drug Sales by Region (2027-2032) & (k units) Table 20. Global Hormone Disorder Drug Sales Market Share by Region (2021-2026) Table 21. Global Hormone Disorder Drug Sales Market Share by Region (2027-2032) Table 22. Global Hormone Disorder Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Hormone Disorder Drug Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Hormone Disorder Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Hormone Disorder Drug Sales Market Share by Manufacturers (2021-2026) Table 26. Global Hormone Disorder Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Hormone Disorder Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Hormone Disorder Drug Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Hormone Disorder Drug Manufacturers, Product Type & Application Table 30. Global Hormone Disorder Drug Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Hormone Disorder Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Hormone Disorder Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Hormone Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Hormone Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Hormone Disorder Drug Revenue Market Share by Type (2021-2026) Table 37. Global Hormone Disorder Drug Revenue Market Share by Type (2027-2032) Table 38. Global Hormone Disorder Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Hormone Disorder Drug Sales by Type (2021-2026) & (k units) Table 40. Global Hormone Disorder Drug Sales by Type (2027-2032) & (k units) Table 41. Global Hormone Disorder Drug Sales Market Share by Type (2021-2026) Table 42. Global Hormone Disorder Drug Sales Market Share by Type (2027-2032) Table 43. Global Hormone Disorder Drug Price by Type (2021-2026) & (US$/unit) Table 44. Global Hormone Disorder Drug Price by Type (2027-2032) & (US$/unit) Table 45. Global Hormone Disorder Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Hormone Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Hormone Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Hormone Disorder Drug Revenue Market Share by Application (2021-2026) Table 49. Global Hormone Disorder Drug Revenue Market Share by Application (2027-2032) Table 50. Global Hormone Disorder Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Hormone Disorder Drug Sales by Application (2021-2026) & (k units) Table 52. Global Hormone Disorder Drug Sales by Application (2027-2032) & (k units) Table 53. Global Hormone Disorder Drug Sales Market Share by Application (2021-2026) Table 54. Global Hormone Disorder Drug Sales Market Share by Application (2027-2032) Table 55. Global Hormone Disorder Drug Price by Application (2021-2026) & (US$/unit) Table 56. Global Hormone Disorder Drug Price by Application (2027-2032) & (US$/unit) Table 57. Abbott Company Information Table 58. Abbott Business Overview Table 59. Abbott Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Abbott Hormone Disorder Drug Product Portfolio Table 61. Abbott Recent Development Table 62. Teva Pharmaceutical Industries Ltd Company Information Table 63. Teva Pharmaceutical Industries Ltd Business Overview Table 64. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product Portfolio Table 66. Teva Pharmaceutical Industries Ltd Recent Development Table 67. Sun Pharmaceutical Industries Ltd Company Information Table 68. Sun Pharmaceutical Industries Ltd Business Overview Table 69. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product Portfolio Table 71. Sun Pharmaceutical Industries Ltd Recent Development Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Sanofi Hormone Disorder Drug Product Portfolio Table 76. Sanofi Recent Development Table 77. Novartis AG Company Information Table 78. Novartis AG Business Overview Table 79. Novartis AG Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Novartis AG Hormone Disorder Drug Product Portfolio Table 81. Novartis AG Recent Development Table 82. Merck KGaA Company Information Table 83. Merck KGaA Business Overview Table 84. Merck KGaA Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Merck KGaA Hormone Disorder Drug Product Portfolio Table 86. Merck KGaA Recent Development Table 87. Lilly Company Information Table 88. Lilly Business Overview Table 89. Lilly Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Lilly Hormone Disorder Drug Product Portfolio Table 91. Lilly Recent Development Table 92. Ferring B.V Company Information Table 93. Ferring B.V Business Overview Table 94. Ferring B.V Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Ferring B.V Hormone Disorder Drug Product Portfolio Table 96. Ferring B.V Recent Development Table 97. PT. Daewoong Pharmaceutical Company Company Information Table 98. PT. Daewoong Pharmaceutical Company Business Overview Table 99. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product Portfolio Table 101. PT. Daewoong Pharmaceutical Company Recent Development Table 102. Mayne Pharma Group Limited Company Information Table 103. Mayne Pharma Group Limited Business Overview Table 104. Mayne Pharma Group Limited Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Mayne Pharma Group Limited Hormone Disorder Drug Product Portfolio Table 106. Mayne Pharma Group Limited Recent Development Table 107. Ipsen Pharma Company Information Table 108. Ipsen Pharma Business Overview Table 109. Ipsen Pharma Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Ipsen Pharma Hormone Disorder Drug Product Portfolio Table 111. Ipsen Pharma Recent Development Table 112. Genentech, Inc Company Information Table 113. Genentech, Inc Business Overview Table 114. Genentech, Inc Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Genentech, Inc Hormone Disorder Drug Product Portfolio Table 116. Genentech, Inc Recent Development Table 117. F. Hoffmann-La Roche Ltd Company Information Table 118. F. Hoffmann-La Roche Ltd Business Overview Table 119. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product Portfolio Table 121. F. Hoffmann-La Roche Ltd Recent Development Table 122. Bausch Health Companies Inc Company Information Table 123. Bausch Health Companies Inc Business Overview Table 124. Bausch Health Companies Inc Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Bausch Health Companies Inc Hormone Disorder Drug Product Portfolio Table 126. Bausch Health Companies Inc Recent Development Table 127. Amneal Pharmaceutical Inc Company Information Table 128. Amneal Pharmaceutical Inc Business Overview Table 129. Amneal Pharmaceutical Inc Hormone Disorder Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Amneal Pharmaceutical Inc Hormone Disorder Drug Product Portfolio Table 131. Amneal Pharmaceutical Inc Recent Development Table 132. North America Hormone Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 133. North America Hormone Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 134. North America Hormone Disorder Drug Sales by Type (2021-2026) & (k units) Table 135. North America Hormone Disorder Drug Sales by Type (2027-2032) & (k units) Table 136. North America Hormone Disorder Drug Sales Price by Type (2021-2026) & (US$/unit) Table 137. North America Hormone Disorder Drug Sales Price by Type (2027-2032) & (US$/unit) Table 138. North America Hormone Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Hormone Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Hormone Disorder Drug Sales by Application (2021-2026) & (k units) Table 141. North America Hormone Disorder Drug Sales by Application (2027-2032) & (k units) Table 142. North America Hormone Disorder Drug Sales Price by Application (2021-2026) & (US$/unit) Table 143. North America Hormone Disorder Drug Sales Price by Application (2027-2032) & (US$/unit) Table 144. North America Hormone Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Hormone Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. North America Hormone Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. North America Hormone Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. North America Hormone Disorder Drug Sales by Country (2021-2026) & (k units) Table 149. North America Hormone Disorder Drug Sales by Country (2027-2032) & (k units) Table 150. North America Hormone Disorder Drug Sales Price by Country (2021-2026) & (US$/unit) Table 151. North America Hormone Disorder Drug Sales Price by Country (2027-2032) & (US$/unit) Table 152. United States Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 153. Canada Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 154. Mexico Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 155. Europe Hormone Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Hormone Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Hormone Disorder Drug Sales by Type (2021-2026) & (k units) Table 158. Europe Hormone Disorder Drug Sales by Type (2027-2032) & (k units) Table 159. Europe Hormone Disorder Drug Sales Price by Type (2021-2026) & (US$/unit) Table 160. Europe Hormone Disorder Drug Sales Price by Type (2027-2032) & (US$/unit) Table 161. Europe Hormone Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Hormone Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Hormone Disorder Drug Sales by Application (2021-2026) & (k units) Table 164. Europe Hormone Disorder Drug Sales by Application (2027-2032) & (k units) Table 165. Europe Hormone Disorder Drug Sales Price by Application (2021-2026) & (US$/unit) Table 166. Europe Hormone Disorder Drug Sales Price by Application (2027-2032) & (US$/unit) Table 167. Europe Hormone Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Hormone Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Europe Hormone Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Europe Hormone Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 171. Europe Hormone Disorder Drug Sales by Country (2021-2026) & (k units) Table 172. Europe Hormone Disorder Drug Sales by Country (2027-2032) & (k units) Table 173. Europe Hormone Disorder Drug Sales Price by Country (2021-2026) & (US$/unit) Table 174. Europe Hormone Disorder Drug Sales Price by Country (2027-2032) & (US$/unit) Table 175. Germany Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 176. France Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 177. U.K. Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 178. Italy Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 179. Russia Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 180. Spain Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 181. Netherlands Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 182. Switzerland Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 183. Sweden Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 184. Poland Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 185. China Hormone Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 186. China Hormone Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 187. China Hormone Disorder Drug Sales by Type (2021-2026) & (k units) Table 188. China Hormone Disorder Drug Sales by Type (2027-2032) & (k units) Table 189. China Hormone Disorder Drug Sales Price by Type (2021-2026) & (US$/unit) Table 190. China Hormone Disorder Drug Sales Price by Type (2027-2032) & (US$/unit) Table 191. China Hormone Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 192. China Hormone Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 193. China Hormone Disorder Drug Sales by Application (2021-2026) & (k units) Table 194. China Hormone Disorder Drug Sales by Application (2027-2032) & (k units) Table 195. China Hormone Disorder Drug Sales Price by Application (2021-2026) & (US$/unit) Table 196. China Hormone Disorder Drug Sales Price by Application (2027-2032) & (US$/unit) Table 197. Asia Hormone Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 198. Asia Hormone Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 199. Asia Hormone Disorder Drug Sales by Type (2021-2026) & (k units) Table 200. Asia Hormone Disorder Drug Sales by Type (2027-2032) & (k units) Table 201. Asia Hormone Disorder Drug Sales Price by Type (2021-2026) & (US$/unit) Table 202. Asia Hormone Disorder Drug Sales Price by Type (2027-2032) & (US$/unit) Table 203. Asia Hormone Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 204. Asia Hormone Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 205. Asia Hormone Disorder Drug Sales by Application (2021-2026) & (k units) Table 206. Asia Hormone Disorder Drug Sales by Application (2027-2032) & (k units) Table 207. Asia Hormone Disorder Drug Sales Price by Application (2021-2026) & (US$/unit) Table 208. Asia Hormone Disorder Drug Sales Price by Application (2027-2032) & (US$/unit) Table 209. Asia Hormone Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. Asia Hormone Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. Asia Hormone Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. Asia Hormone Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 213. Asia Hormone Disorder Drug Sales by Country (2021-2026) & (k units) Table 214. Asia Hormone Disorder Drug Sales by Country (2027-2032) & (k units) Table 215. Asia Hormone Disorder Drug Sales Price by Country (2021-2026) & (US$/unit) Table 216. Asia Hormone Disorder Drug Sales Price by Country (2027-2032) & (US$/unit) Table 217. Japan Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 218. South Korea Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 219. India Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 220. Australia Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 221. Taiwan Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 222. Southeast Asia Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 223. SAMEA Hormone Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 224. SAMEA Hormone Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 225. SAMEA Hormone Disorder Drug Sales by Type (2021-2026) & (k units) Table 226. SAMEA Hormone Disorder Drug Sales by Type (2027-2032) & (k units) Table 227. SAMEA Hormone Disorder Drug Sales Price by Type (2021-2026) & (US$/unit) Table 228. SAMEA Hormone Disorder Drug Sales Price by Type (2027-2032) & (US$/unit) Table 229. SAMEA Hormone Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 230. SAMEA Hormone Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 231. SAMEA Hormone Disorder Drug Sales by Application (2021-2026) & (k units) Table 232. SAMEA Hormone Disorder Drug Sales by Application (2027-2032) & (k units) Table 233. SAMEA Hormone Disorder Drug Sales Price by Application (2021-2026) & (US$/unit) Table 234. SAMEA Hormone Disorder Drug Sales Price by Application (2027-2032) & (US$/unit) Table 235. SAMEA Hormone Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. SAMEA Hormone Disorder Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. SAMEA Hormone Disorder Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. SAMEA Hormone Disorder Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 239. SAMEA Hormone Disorder Drug Sales by Country (2021-2026) & (k units) Table 240. SAMEA Hormone Disorder Drug Sales by Country (2027-2032) & (k units) Table 241. SAMEA Hormone Disorder Drug Sales Price by Country (2021-2026) & (US$/unit) Table 242. SAMEA Hormone Disorder Drug Sales Price by Country (2027-2032) & (US$/unit) Table 243. Brazil Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 244. Argentina Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 245. Chile Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 246. Colombia Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 247. Peru Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 248. Saudi Arabia Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 249. Israel Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 250. UAE Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 251. Turkey Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 252. Iran Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 253. Egypt Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Table 254. Key Raw Materials Table 255. Raw Materials Key Suppliers Table 256. Hormone Disorder Drug Distributors List Table 257. Hormone Disorder Drug Customers List Table 258. Research Programs/Design for This Report Table 259. Authors List of This Report Table 260. Secondary Sources Table 261. Primary Sources List of Figures Figure 1. Hormone Disorder Drug Image Figure 2. Global Hormone Disorder Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hormone Disorder Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Growth Hormone Stimulator Image Figure 5. Growth Hormone Inhibitor Image Figure 6. Global Hormone Disorder Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hormone Disorder Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Dwarfism Image Figure 9. Gigantism Image Figure 10. Other Image Figure 11. Global Hormone Disorder Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Figure 13. Global Hormone Disorder Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Hormone Disorder Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Hormone Disorder Drug Revenue Market Share by Region (2021-2032) Figure 16. Global Hormone Disorder Drug Sales (2021-2032) & (k units) Figure 17. Global Hormone Disorder Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Hormone Disorder Drug Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Hormone Disorder Drug Sales YoY (2021-2032) & (k units) Figure 20. Europe Hormone Disorder Drug Sales YoY (2021-2032) & (k units) Figure 21. China Hormone Disorder Drug Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Hormone Disorder Drug Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Hormone Disorder Drug Sales YoY (2021-2032) & (k units) Figure 24. Global Hormone Disorder Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Hormone Disorder Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Hormone Disorder Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Hormone Disorder Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Hormone Disorder Drug Revenue Market Share by Type (2021-2032) Figure 30. Global Hormone Disorder Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Hormone Disorder Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Hormone Disorder Drug Sales Market Share by Type (2021-2032) Figure 33. Global Hormone Disorder Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Hormone Disorder Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Hormone Disorder Drug Revenue Market Share by Application (2021-2032) Figure 36. Global Hormone Disorder Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Hormone Disorder Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Hormone Disorder Drug Sales Market Share by Application (2021-2032) Figure 39. North America Hormone Disorder Drug Revenue Share by Type (2021-2032) Figure 40. North America Hormone Disorder Drug Sales Share by Type (2021-2032) Figure 41. North America Hormone Disorder Drug Revenue Share by Application (2021-2032) Figure 42. North America Hormone Disorder Drug Sales Share by Application (2021-2032) Figure 43. North America Hormone Disorder Drug Revenue Share by Country (2021-2032) Figure 44. North America Hormone Disorder Drug Sales Share by Country (2021-2032) Figure 45. Europe Hormone Disorder Drug Revenue Share by Type (2021-2032) Figure 46. Europe Hormone Disorder Drug Sales Share by Type (2021-2032) Figure 47. Europe Hormone Disorder Drug Revenue Share by Application (2021-2032) Figure 48. Europe Hormone Disorder Drug Sales Share by Application (2021-2032) Figure 49. Europe Hormone Disorder Drug Revenue Share by Country (2021-2032) Figure 50. Europe Hormone Disorder Drug Sales Share by Country (2021-2032) Figure 51. China Hormone Disorder Drug Revenue Share by Type (2021-2032) Figure 52. China Hormone Disorder Drug Sales Share by Type (2021-2032) Figure 53. China Hormone Disorder Drug Revenue Share by Application (2021-2032) Figure 54. China Hormone Disorder Drug Sales Share by Application (2021-2032) Figure 55. Asia Hormone Disorder Drug Revenue Share by Type (2021-2032) Figure 56. Asia Hormone Disorder Drug Sales Share by Type (2021-2032) Figure 57. Asia Hormone Disorder Drug Revenue Share by Application (2021-2032) Figure 58. Asia Hormone Disorder Drug Sales Share by Application (2021-2032) Figure 59. Asia Hormone Disorder Drug Revenue Share by Country (2021-2032) Figure 60. Asia Hormone Disorder Drug Sales Share by Country (2021-2032) Figure 61. SAMEA Hormone Disorder Drug Revenue Share by Type (2021-2032) Figure 62. SAMEA Hormone Disorder Drug Sales Share by Type (2021-2032) Figure 63. SAMEA Hormone Disorder Drug Revenue Share by Application (2021-2032) Figure 64. SAMEA Hormone Disorder Drug Sales Share by Application (2021-2032) Figure 65. SAMEA Hormone Disorder Drug Revenue Share by Country (2021-2032) Figure 66. SAMEA Hormone Disorder Drug Sales Share by Country (2021-2032) Figure 67. Hormone Disorder Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Hormone Disorder Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Growth Hormone Stimulator
  • Growth Hormone Inhibitor
Applications
  • Dwarfism
  • Gigantism
  • Other
Companies covered
  • Abbott
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Novartis AG
  • Merck KGaA
  • Lilly
  • Ferring B.V
  • PT. Daewoong Pharmaceutical Company
  • Mayne Pharma Group Limited
  • Ipsen Pharma
  • Genentech, Inc
  • F. Hoffmann-La Roche Ltd
  • Bausch Health Companies Inc
  • Amneal Pharmaceutical Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hormone Disorder Drug Market by Type
  3. 1.2.1 Global Hormone Disorder Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Growth Hormone Stimulator
  5. 1.2.3 Growth Hormone Inhibitor
  6. 1.3 Hormone Disorder Drug Market by Application
  7. 1.3.1 Global Hormone Disorder Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Dwarfism
  9. 1.3.3 Gigantism
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Hormone Disorder Drug Market Dynamics
  1. 2.1 Hormone Disorder Drug Industry Trends
  2. 2.2 Hormone Disorder Drug Industry Drivers
  3. 2.3 Hormone Disorder Drug Industry Opportunities and Challenges
  4. 2.4 Hormone Disorder Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hormone Disorder Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hormone Disorder Drug Revenue by Region
  3. 3.2.1 Global Hormone Disorder Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hormone Disorder Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Hormone Disorder Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Hormone Disorder Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hormone Disorder Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hormone Disorder Drug Sales by Region
  9. 3.4.1 Global Hormone Disorder Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hormone Disorder Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Hormone Disorder Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Hormone Disorder Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hormone Disorder Drug Revenue by Manufacturers
  2. 4.1.1 Global Hormone Disorder Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hormone Disorder Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hormone Disorder Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hormone Disorder Drug Sales by Manufacturers
  6. 4.2.1 Global Hormone Disorder Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hormone Disorder Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hormone Disorder Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hormone Disorder Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hormone Disorder Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hormone Disorder Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hormone Disorder Drug Manufacturers, Product Type & Application
  13. 4.7 Global Hormone Disorder Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hormone Disorder Drug Market CR5 and HHI
  16. 4.8.2 2025 Hormone Disorder Drug Tier 1, Tier 2, and Tier 3
5 Hormone Disorder Drug Market by Type
  1. 5.1 Global Hormone Disorder Drug Revenue by Type
  2. 5.1.1 Global Hormone Disorder Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hormone Disorder Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hormone Disorder Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hormone Disorder Drug Sales by Type
  6. 5.2.1 Global Hormone Disorder Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hormone Disorder Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Hormone Disorder Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hormone Disorder Drug Price by Type
6 Hormone Disorder Drug Market by Application
  1. 6.1 Global Hormone Disorder Drug Revenue by Application
  2. 6.1.1 Global Hormone Disorder Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hormone Disorder Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hormone Disorder Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hormone Disorder Drug Sales by Application
  6. 6.2.1 Global Hormone Disorder Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hormone Disorder Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Hormone Disorder Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hormone Disorder Drug Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Hormone Disorder Drug Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Teva Pharmaceutical Industries Ltd
  8. 7.2.1 Teva Pharmaceutical Industries Ltd Company Information
  9. 7.2.2 Teva Pharmaceutical Industries Ltd Business Overview
  10. 7.2.3 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product Portfolio
  12. 7.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
  13. 7.3 Sun Pharmaceutical Industries Ltd
  14. 7.3.1 Sun Pharmaceutical Industries Ltd Company Information
  15. 7.3.2 Sun Pharmaceutical Industries Ltd Business Overview
  16. 7.3.3 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product Portfolio
  18. 7.3.5 Sun Pharmaceutical Industries Ltd Recent Developments
  19. 7.4 Sanofi
  20. 7.4.1 Sanofi Company Information
  21. 7.4.2 Sanofi Business Overview
  22. 7.4.3 Sanofi Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sanofi Hormone Disorder Drug Product Portfolio
  24. 7.4.5 Sanofi Recent Developments
  25. 7.5 Novartis AG
  26. 7.5.1 Novartis AG Company Information
  27. 7.5.2 Novartis AG Business Overview
  28. 7.5.3 Novartis AG Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novartis AG Hormone Disorder Drug Product Portfolio
  30. 7.5.5 Novartis AG Recent Developments
  31. 7.6 Merck KGaA
  32. 7.6.1 Merck KGaA Company Information
  33. 7.6.2 Merck KGaA Business Overview
  34. 7.6.3 Merck KGaA Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Merck KGaA Hormone Disorder Drug Product Portfolio
  36. 7.6.5 Merck KGaA Recent Developments
  37. 7.7 Lilly
  38. 7.7.1 Lilly Company Information
  39. 7.7.2 Lilly Business Overview
  40. 7.7.3 Lilly Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lilly Hormone Disorder Drug Product Portfolio
  42. 7.7.5 Lilly Recent Developments
  43. 7.8 Ferring B.V
  44. 7.8.1 Ferring B.V Company Information
  45. 7.8.2 Ferring B.V Business Overview
  46. 7.8.3 Ferring B.V Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Ferring B.V Hormone Disorder Drug Product Portfolio
  48. 7.8.5 Ferring B.V Recent Developments
  49. 7.9 PT. Daewoong Pharmaceutical Company
  50. 7.9.1 PT. Daewoong Pharmaceutical Company Company Information
  51. 7.9.2 PT. Daewoong Pharmaceutical Company Business Overview
  52. 7.9.3 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product Portfolio
  54. 7.9.5 PT. Daewoong Pharmaceutical Company Recent Developments
  55. 7.10 Mayne Pharma Group Limited
  56. 7.10.1 Mayne Pharma Group Limited Company Information
  57. 7.10.2 Mayne Pharma Group Limited Business Overview
  58. 7.10.3 Mayne Pharma Group Limited Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mayne Pharma Group Limited Hormone Disorder Drug Product Portfolio
  60. 7.10.5 Mayne Pharma Group Limited Recent Developments
  61. 7.11 Ipsen Pharma
  62. 7.11.1 Ipsen Pharma Company Information
  63. 7.11.2 Ipsen Pharma Business Overview
  64. 7.11.3 Ipsen Pharma Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Ipsen Pharma Hormone Disorder Drug Product Portfolio
  66. 7.11.5 Ipsen Pharma Recent Developments
  67. 7.12 Genentech, Inc
  68. 7.12.1 Genentech, Inc Company Information
  69. 7.12.2 Genentech, Inc Business Overview
  70. 7.12.3 Genentech, Inc Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Genentech, Inc Hormone Disorder Drug Product Portfolio
  72. 7.12.5 Genentech, Inc Recent Developments
  73. 7.13 F. Hoffmann-La Roche Ltd
  74. 7.13.1 F. Hoffmann-La Roche Ltd Company Information
  75. 7.13.2 F. Hoffmann-La Roche Ltd Business Overview
  76. 7.13.3 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product Portfolio
  78. 7.13.5 F. Hoffmann-La Roche Ltd Recent Developments
  79. 7.14 Bausch Health Companies Inc
  80. 7.14.1 Bausch Health Companies Inc Company Information
  81. 7.14.2 Bausch Health Companies Inc Business Overview
  82. 7.14.3 Bausch Health Companies Inc Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bausch Health Companies Inc Hormone Disorder Drug Product Portfolio
  84. 7.14.5 Bausch Health Companies Inc Recent Developments
  85. 7.15 Amneal Pharmaceutical Inc
  86. 7.15.1 Amneal Pharmaceutical Inc Company Information
  87. 7.15.2 Amneal Pharmaceutical Inc Business Overview
  88. 7.15.3 Amneal Pharmaceutical Inc Hormone Disorder Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Amneal Pharmaceutical Inc Hormone Disorder Drug Product Portfolio
  90. 7.15.5 Amneal Pharmaceutical Inc Recent Developments
8 North America
  1. 8.1 North America Hormone Disorder Drug Market Size by Type
  2. 8.1.1 North America Hormone Disorder Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Hormone Disorder Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Hormone Disorder Drug Price by Type (2021-2032)
  5. 8.2 North America Hormone Disorder Drug Market Size by Application
  6. 8.2.1 North America Hormone Disorder Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Hormone Disorder Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Hormone Disorder Drug Price by Application (2021-2032)
  9. 8.3 North America Hormone Disorder Drug Market Size by Country
  10. 8.3.1 North America Hormone Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hormone Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hormone Disorder Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Hormone Disorder Drug Market Size by Type
  2. 9.1.1 Europe Hormone Disorder Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hormone Disorder Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Hormone Disorder Drug Price by Type (2021-2032)
  5. 9.2 Europe Hormone Disorder Drug Market Size by Application
  6. 9.2.1 Europe Hormone Disorder Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hormone Disorder Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Hormone Disorder Drug Price by Application (2021-2032)
  9. 9.3 Europe Hormone Disorder Drug Market Size by Country
  10. 9.3.1 Europe Hormone Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hormone Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hormone Disorder Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Hormone Disorder Drug Market Size by Type
  2. 10.1.1 China Hormone Disorder Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Hormone Disorder Drug Sales by Type (2021-2032)
  4. 10.1.3 China Hormone Disorder Drug Price by Type (2021-2032)
  5. 10.2 China Hormone Disorder Drug Market Size by Application
  6. 10.2.1 China Hormone Disorder Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Hormone Disorder Drug Sales by Application (2021-2032)
  8. 10.2.3 China Hormone Disorder Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hormone Disorder Drug Market Size by Type
  2. 11.1.1 Asia Hormone Disorder Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hormone Disorder Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Hormone Disorder Drug Price by Type (2021-2032)
  5. 11.2 Asia Hormone Disorder Drug Market Size by Application
  6. 11.2.1 Asia Hormone Disorder Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hormone Disorder Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Hormone Disorder Drug Price by Application (2021-2032)
  9. 11.3 Asia Hormone Disorder Drug Market Size by Country
  10. 11.3.1 Asia Hormone Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hormone Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hormone Disorder Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hormone Disorder Drug Market Size by Type
  2. 12.1.1 SAMEA Hormone Disorder Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hormone Disorder Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hormone Disorder Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Hormone Disorder Drug Market Size by Application
  6. 12.2.1 SAMEA Hormone Disorder Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hormone Disorder Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hormone Disorder Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Hormone Disorder Drug Market Size by Country
  10. 12.3.1 SAMEA Hormone Disorder Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hormone Disorder Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hormone Disorder Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hormone Disorder Drug Value Chain Analysis
  2. 13.1.1 Hormone Disorder Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hormone Disorder Drug Production Mode & Process
  6. 13.2 Hormone Disorder Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hormone Disorder Drug Distributors
  9. 13.2.3 Hormone Disorder Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst